Novo Nordisk, Roche shares fall as Jefferies turns bearish amid structural risks By Investing.com
Update: 2025-10-27
Description
Pharma giants Novo Nordisk and Roche stumble! Find out why Jefferies slapped them with Underperform ratings, citing patent cliffs, competition, and overblown valuations. Is it time to bail on these market darlings? Tune in for a reality check on the future of blockbuster drugs and smart investing.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel




